ARTICLE
17 February 2016

FDA Corrects And Amends Final Rule On Cgmps, Hazard Analysis, And Risk-Based Preventive Controls For Human Food

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the January 22 and January 25, 2016, Federal Registers, FDA corrected and amended a final rule published in the September 17, 2015, Federal Register amending the regulation for CGMPs in manufacturing...
United States Food, Drugs, Healthcare, Life Sciences

In the January 22 and January 25, 2016, Federal Registers, FDA corrected and amended a final rule published in the September 17, 2015, Federal Register amending the regulation for CGMPs in manufacturing, packing, or holding human food to modernize it and add requirements for domestic and foreign facilities required to register under the U.S. Food, Drug, and Cosmetic Act ("FDCA") to establish and implement hazard analysis and risk-based preventive controls. The final rule also revised certain definitions in the regulation to clarify the scope of the exemption from registration requirements provided by FDCA for "farms." The January 22 and 25, 2016, notices correct editorial and inadvertent errors in the final rule.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More